Turtle Cameron bought DMRA
March 23, 2026 · Form 4 insider transaction
Turtle Cameron bought 37,313 shares of Damora Therapeutics, Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 2 days after the transaction.
Direction
Acquired (buy-side)
Shares
37,313
Price
$0.00
Total value
N/A
InsiderTurtle Cameron
Role—
SecurityStock Option (right to buy)
Transaction codeA: Grant or award
Transaction dateMarch 23, 2026
Filing dateMarch 25, 2026
Shares owned after37,313
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
This option represents a right to purchase shares of common stock of the Issuer. This option will vest in equal monthly installments through March 23, 2029, subject to the Reporting Person's continued service to the Issuer on each such vesting date.